Investigation of SEN Virus Infection in Patients with Cryptogenic Acute Liver Failure, Hepatitis-Associated Aplastic Anemia, or Acute and Chronic Non-A-E Hepatitis

Journal of Infectious Diseases

Volumn 188, Issue 10, 2003, Pages 1545-1552

  Umemura, Takeji ^a,d   Tanaka, Eiji ^d   Ostapowicz, George ^c,h   Brown, Kevin E ^b   Heringlake, Stefan ^e,i   Tassopoulos, Nicolaos C ^f   Wang, Richard Y H ^a   Yeo, Anthony E T ^a,j   Shih, J Wai Kuo ^a   Orii, Koji ^d   Young, Neal S ^b   Hatzakis, Angelos ^g   Manns, Michael P ^e   Lee, William M ^c   Kiyosawa, Kendo ^d   Alter, Harvey J ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Western Attica General Hospital   (Greece)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h GOLD COAST UNIVERSITY HOSPITAL   (Australia)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

^j Jacobus Pharmaceutical Co Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; HEPATITIS; HEPATITIS NON A TO E; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEN VIRUS; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CHILD; CIRCOVIRIDAE; CIRCOVIRIDAE INFECTIONS; DNA, VIRAL; FEMALE; GERMANY; GREECE; HEPATITIS VIRUSES; HEPATITIS, CHRONIC; HUMANS; JAPAN; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; UNITED STATES;

EID: 10744231622     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379216     Document Type: Article

References (32)

1. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321:1494-500.
2. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995; 15:110-20.
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327:1899-905.
4. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89:1836-9.
5. Hibbs JR, Frickhofen N, Rosenfeld SJ, et al. Aplastic anemia and viral hepatitis: non-A, non-B, non-C? JAMA 1992; 267:2051-4.
6. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med 1997; 336:1059-64.
7. Ferraz ML, Silva AE, Macdonald GA, Tsarev SA, Di Biscelgie AM, Lucey MR. Fulminant hepatitis in patients undergoing liver transplantation: evidence for a non-A, non-B, non-C, non-D, and non-E syndrome. Liver Transpl Surg 1996; 2:60-6.
8. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1:564-9.
9. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271:505-8.
10. Nishizawa T, Okamoto H, Konisi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241:92-7.
11. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336:747-54.
12. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997; 37:569-72.
13. Muñoz SJ, Alter HJ, Nakatsuji Y, et al. The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology. Blood 1999; 94:1460-4.
14. Simmonds P, Davidson F, Lycett C, et al. Detection of a novel DNA virus (TT virus) in blood donors and blood products. Lancet 1998; 352:191-5.
15. Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with live disease. Lancet 1998; 352:195-7.
16. Matsumoto A, Yeo AET, Shih JWK, Tanaka E, Kiyosawa K, Alter HJ. Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology 1999; 30:283-8.
17. Primi D, Fiordalisi G, Mantero JL, et al. Identification of SENV genotypes: international publication number WO0028039. Available at: http://ep.espacenet.com/.
18. Tanaka Y, Primi D, Wang RYH, et al. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 2001; 183:359-67.
19. Umemura T, Tanaka Y, Kiyosawa K, Alter HJ, Shih JWK. Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus). FEBS Lett 2002; 510:171-4.
20. Umemura T, Yeo AET, Sottini A, et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001; 33:1303-11.
21. Umemura T, Alter HJ, Tanaka E, et al. Association between SEN virus infection and hepatitis C in Japan. J Infect Dis 2001; 184:1246-51.
22. Umemura T, Alter HJ, Tanaka E, et al. SEN virus: response to interferon-alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology 2002; 35:953-9.
23. Tassopoulos NC, Hatzakis A, Delladetsima I, Koutelou MG, Todoulos A, Miriagou V. Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology 1992; 102:969-72.
24. Anastassopoulou CG, Paraskevis D, Tassopoulos NC, et al. Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece. J Med Virol 2000; 61:319-26.
25. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-54.
26. Lee WM. Acute liver failure. N Engl J Med 1993; 329:1862-72.
27. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-38.
28. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1987; 316:521-8.
29. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. Prevalence and implication of a newly identified infectious agent (SEN Virus) in Taiwan. J Infect Dis 2002; 185:389-92.
30. Safadi R, Or R, Ilan Y, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001; 27:183-90.
31. Wilson LE, Umemura T, Astemborski J, et al. Dynamics of SEN virus infection among injection drug users. J Infect Dis 2001; 184:1315-9.
32. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. SEN virus infection in patients with chronic hepatitis C: preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin. J Infect Dis 2003; 187:307-10.